A Multicentre, Multinational, Open-Label, 52-Week Extension Study of Gemigliptin (LC15-0444) Monotherapy in Patients with Type 2 Diabetes Mellitus

por Yang, Sae Jeong, Min, Kyung Wan, Gupta, Sandeep Kumar, Park, Joong Yeol, Shivane, Vyankatesh K., Agarwal, Pankaj Kumar, Kim, Doo Man, Kim, Yong Seung, Baik, Sei Hyun
Publicado 2021

Oral glucose lowering with linagliptin and metformin compared with linagliptin alone as initial treatment in Asian patients with newly diagnosed type 2 diabetes and marked hypergly...

por Ma, Ronald CW, Del Prato, Stefano, Gallwitz, Baptist, Shivane, Vyankatesh K, Lewis‐D'Agostino, Diane, Bailes, Zelie, Patel, Sanjay, Lee, Jisoo, von Eynatten, Maximilian, Di Domenico, Maximiliano, Ross, Stuart A
Publicado 2017